US Patent Issued to HRY Z (Shanghai) Biotech, HRY Z (Guangzhou) Biotech on May 27 for "Methods of cancer treatment using activated t cells" (Chinese Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,597, issued on May 27, was assigned to HRY Z (Shanghai) Biotech Co. (Shanghai) and HRY Z (Guangzhou) Biotech Co. (Guangzhou, China).

"Methods of cancer treatment using activated t cells" was invented by Xiangjun Zhou (Guangdong, China), Jin Li (Guangdong, China), Yanyan Han (Guangdong, China), Dongyun Wu (Guangdong, China), Junyun Liu (Guangdong, China), Longqing Tang (Guangdong, China) and Ran Tao (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method of treating a cancer in an individual using activated T cells or PBMCs induced by antigen presenting cells (such as dendritic cells) loaded with a plu...